Literature DB >> 31997427

Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.

Kuo Tong1,2,3, Wei Zhu1, Hua Fu4, Fang Cao5, Shu Wang5, Wenxuan Zhou1,3, Chongmei Liu6, Dongliang Chen7, Songqing Fan8, Zhongliang Hu1,3.   

Abstract

AIMS: Papillary renal neoplasm with reverse polarity (PRNRP) is a newly documented rare tumour type. Its molecular pathological features have thus far been very little studied. METHODS AND
RESULTS: There were 13 PRNRP cases including 3 The Cancer Genome Atlas (TCGA) cases and our 10 cases in this study. The 3 TCGA cases were found by a combined analysis of GATA3 mRNA expression levels and digital slides from the TCGA papillary renal cell carcinoma project. KRAS codon 12 mutations were identified in the three PRNRPs from TCGA. Of our 10 PRNRP cases, the mutations were also discovered using Sanger sequencing in seven (77.8%) of nine cases with available DNA, where KRAS p.G12V (n = 3), p.G12D (n = 2), p.G12R (n = 1) and p.G12C (n = 1) alterations were found. PRNRP shared similar gene expression profiles with renal distal tubules via an interprofile correlation analysis. Gene set enrichment analysis revealed that genes involved in 'KEGG aldosterone regulated sodium reabsorption' or 'hallmark apical surface' were enriched in PRNRP. Moreover, polarised immunostaining patterns for L1CAM and EMA in the distal tubule were maintained in PRNRP.
CONCLUSIONS: These results imply that the tumour potentially originates from the distal tubule, especially from the cortical collecting duct, and probably retains its cell polarity, except for nuclear inversion. We therefore propose that oncocytic papillary renal neoplasm with inverted nuclei (OPRNIN) is a better name for this tumour type. OPRNIN is a kidney site-specific KRAS mutation neoplasm different from conventional papillary renal cell carcinoma.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990KRASzzm321990; Sanger sequencing; bioinformatics; renal cell neoplasms

Mesh:

Substances:

Year:  2020        PMID: 31997427     DOI: 10.1111/his.14084

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.

Authors:  Yutong Wang; Hui Nie; Huiling Li; Zhiming Liao; Xuejie Yang; Xiaoyun He; Jian Ma; Jianhua Zhou; Chunlin Ou
Journal:  Front Med (Lausanne)       Date:  2022-07-05

2.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

3.  Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in MSH6 and Molecular Analysis: Report of a Case and Review of the Literature.

Authors:  Yu Yang; Shweta Dhar; Jennifer Taylor; Bhuvaneswari Krishnan
Journal:  J Kidney Cancer VHL       Date:  2021-04-21

4.  Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.

Authors:  Miaomiao Shen; Xiaona Yin; Yanfeng Bai; Huizhi Zhang; Guoqing Ru; Xianglei He; Xiaodong Teng; Guorong Chen; Ming Zhao
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

5.  Gene expression and methylation profiles show the involvement of POMC in primary hyperparathyroidsm.

Authors:  Wen-Xuan Zhou; Shu Wang; Ting-Chao Wu; Ling-Chao Cheng; Yao Du; Wei Wu; Chen Lin; Xin-Ying Li; Zhong-Liang Hu
Journal:  J Transl Med       Date:  2022-08-16       Impact factor: 8.440

6.  Papillary renal neoplasm with reverse polarity may be a novel renal cell tumor entity with low malignant potential.

Authors:  Tong Yang; Enhao Kang; Longxiao Zhang; Jie Zhuang; Yujun Li; Yanxia Jiang; Han Wang; Wenjuan Yu; Wei Zhang
Journal:  Diagn Pathol       Date:  2022-08-25       Impact factor: 3.196

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.